ASBP
Price:
$1.46
Market Cap:
$5.05M
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingu...[Read more]
Industry
Biotechnology
IPO Date
2025-02-20
Stock Exchange
NASDAQ
Ticker
ASBP
According to Aspire Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 388.19%. This represents a change of 83.56% compared to the average of 211.48% of the last 4 quarters.
The mean historical ROE of Aspire Biopharma Holdings, Inc. over the last ten years is 1.55%. The current 388.19% ROE has changed -74.96% with respect to the historical average. Over the past ten years (40 quarters), ASBP's ROE was at its highest in in the December 2024 quarter at 579.90%. The ROE was at its lowest in in the September 2021 quarter at -5467.86%.
Average
1.55%
Median
418.42%
Minimum
1.16%
Maximum
5.36%
Discovering the peaks and valleys of Aspire Biopharma Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.47%
Maximum Annual ROE = 5.36%
Minimum Annual Increase = -99.98%
Minimum Annual ROE = 1.16%
| Year | ROE | Change |
|---|---|---|
| 2024 | 814.04% | 3.47% |
| 2023 | 22.80% | 1.87% |
| 2022 | 1.16% | -99.98% |
The current ROE of Aspire Biopharma Holdings, Inc. (ASBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
279.33%
5-year avg
1.55%
10-year avg
1.55%
Aspire Biopharma Holdings, Inc.’s ROE is less than Consilium Acquisition Corp I, Ltd. (21.11%), greater than AleAnna, Inc. (-17.06%), greater than Catcha Investment Corp (-4.02%), less than Focus Impact Acquisition Corp. (31.30%), less than Golden Arrow Merger Corp. (726.49%), greater than Collective Audience, Inc. (-99.67%), greater than LIV Capital Acquisition Corp. II (0.10%), greater than Blue Ocean Acquisition Corp. (3.64%), less than Insight Acquisition Corp. (6.31%), less than Integrated Wellness Acquisition Corp (9.32%),
| Company | ROE | Market cap |
|---|---|---|
| 21.11% | $71.50M | |
| -17.06% | $113.85M | |
| -4.02% | $77.57M | |
| 31.30% | $66.31M | |
| 726.49% | $68.63M | |
| -99.67% | $2.00M | |
| 0.10% | $73.34M | |
| 3.64% | $70.57M | |
| 6.31% | $61.93M | |
| 9.32% | $84.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspire Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aspire Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aspire Biopharma Holdings, Inc.'s ROE?
How is the ROE calculated for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the highest ROE for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the 3-year average ROE for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the 5-year average ROE for Aspire Biopharma Holdings, Inc. (ASBP)?
How does the current ROE for Aspire Biopharma Holdings, Inc. (ASBP) compare to its historical average?